| Literature DB >> 24887457 |
Michael R Green1, Carolina Vicente-Dueñas2, Isabel Romero-Camarero3, Chih Long Liu4, Bo Dai4, Inés González-Herrero3, Idoia García-Ramírez3, Esther Alonso-Escudero3, Javeed Iqbal5, Wing C Chan5, Elena Campos-Sanchez6, Alberto Orfao7, Belén Pintado8, Teresa Flores9, Oscar Blanco10, Rafael Jiménez11, Jose Angel Martínez-Climent12, Francisco Javier García Criado13, María Begoña García Cenador13, Shuchun Zhao14, Yasodha Natkunam14, Izidore S Lossos15, Ravindra Majeti4, Ari Melnick16, César Cobaleda6, Ash A Alizadeh1, Isidro Sánchez-García2.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be separated into two subtypes based upon molecular features with similarities to germinal centre B-cells (GCB-like) or activated B-cells (ABC-like). Here we identify gain of 3q27.2 as being significantly associated with adverse outcome in DLBCL and linked with the ABC-like subtype. This lesion includes the BCL6 oncogene, but does not alter BCL6 transcript levels or target-gene repression. Separately, we identify expression of BCL6 in a subset of human haematopoietic stem/progenitor cells (HSPCs). We therefore hypothesize that BCL6 may act by 'hit-and-run' oncogenesis. We model this hit-and-run mechanism by transiently expressing Bcl6 within murine HSPCs, and find that it causes mature B-cell lymphomas that lack Bcl6 expression and target-gene repression, are transcriptionally similar to post-GCB cells, and show epigenetic changes that are conserved from HSPCs to mature B-cells. Together, these results suggest that BCL6 may function in a 'hit-and-run' role in lymphomagenesis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24887457 PMCID: PMC4321731 DOI: 10.1038/ncomms4904
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919